AdvertisementLanguage Barrier Means Millions Of Elderly Can't Access Alzheimer's TrialsOctober 31, 2018Josh EibelmanfacebookEmailGetting people of different ethnicities and cultural backgrounds into clinical trials is not only a question of equity, doctors say. It's also a scientific imperative to make sure candidate drugs work and are safe in a broad cross-section of people. (Getty Images)